IMMEDIATE RELEASE AMLODIPINE UBIQUINONE COMPOSITION FOR ENHANCED IMMUNOMODULATORY ACTIVITY

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION

Nimodipine Parenteral Administration

NOVEL TREATMENTS

Method for Enhancing Drug Solubility and Preparing a Drug Composite Material with Enhanced Solubility

STABLE ORAL LIQUID COMPOSITIONS

AMLODIPINE FORMULATIONS

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION

LIQUID NIMODIPINE COMPOSITIONS

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION

APPLICATIONS FOR NICARDIPINE IN PREPARING ANTI-LUNG CANCER PRODUCTS

NIMODIPINE COMPOSITION FREE OF ETHANOL AND PHOSPHOLIPID FOR MOIST HEAT STERILIZATION AND METHOD FOR PREPARING SAME

TOPICAL THERAPEUTIC FORMULATIONS

ADAPTER FOR USE IN A PLANETARY MIXER

SYSTEMS AND METHODS FOR SYMPATHETIC CARDIOPULMONARY NEUROMODULATION

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

BONDED MICROPARTICULATES PREPARATION AND APPLICATIONS THEREOF

DRUG REPURPOSING FOR TREATMENT OF CONGENITAL VASCULAR MALFORMATIONS

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION

STABILIZED PHARMACEUTICAL COMPOSITION OF 1,4-DIHYDROPYRIDINES WITH HYDROGEN ATOM TRANSFER (HAT) ANTIOXIDANTS

METHOD TO PREVENT AND TREAT DIABETIC RETINOPATHY BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

SAFE AND STABLE NIMODIPINE FORMULATION FOR INJECTION AND METHOD FOR PREPARING SAME

POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS

METHOD TO PREVENT AND TREAT GLAUCOMA BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

NON-AQUEOUS LIQUID NIMODIPINE COMPOSITIONS

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING LOW IMPURITY CONCENTRATIONS OF THE SAME

POLYMERIC IRON BINDING COMPOSITIONS AND METHODS OF USE FOR TREATING DISEASES ASSOCIATED WITH EXCESS DAMAGING REACTIVE IRON

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION

ANTIBACTERIAL AGENTS

TOPICAL THERAPEUTIC FORMULATIONS

METHODS OF TREATING COMPLEX REGIONAL PAIN SYNDROME

OSMOTIC PUMP CONTROLLED-RELEASE TABLET OF INSOLUBLE DRUG AND PREPARATION METHOD THEREFOR

ADAPTER FOR USE IN A PLANETARY MIXER

TOPICAL AMLODIPINE SALTS FOR THE TREATMENT OF ANORECTAL DISEASES

CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS

NOSE-TO-BRAIN DELIVERY FORMULATION OF NIMODIPINE, PREPARATION AND USE

COMPOSITION FOR SOLID DISPERSION, SOLID DISPERSION, AND METHOD OF MANUFACTURING THE SOLID DISPERSION

COATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME

METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TREATING MYOCARDIAL STRESS AND FIBROSIS

AMLODIPINE FORMULATIONS

TREATMENT OF PAIN AND VASOCONSTRICTION

METHODS OF TREATING PAIN

TREATMENT OF SCLERODERMA

NOVEL THERAPEUTIC METHOD FOR ENHANCING MITOCHONDRIAL FUNCTION, TREATING MITOCHONDRIAL DISEASES THEREBY, AND COMPOUNDS USED THEREIN

MICRORNA 195 COMPOSITIONS AND METHODS FOR TREATING COGNITIVE IMPAIRMENT

POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING

DEUTERATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASES

APPLICATIONS FOR NICARDIPINE IN PREPARING ANTI-LUNG CANCER PRODUCTS

PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASES

Targeted Therapeutic Lipid Nanoparticles and Methods of Use

COMBINATORY THERAPY FOR PREVENTING, INHIBITING, TREATING, OR REDUCING ANEURYSMS

TOPICAL WIPE CONTAINING NIFEDIPINE AND LIDOCAINE

METHODS OF TREATING EYE PAIN AND EYE DISORDERS

METHODS AND SYSTEMS FOR MAKING POLYMER MICROSPHERES

ADAPTER FOR USE IN A PLANETARY MIXER

NOVEL TREATMENTS

COMPOSITIONS AND METHODS OF MAKING COCRYSTALS USING DIELECTRIC HEATING WITH DISPERSIVE AND DISTRIBUTIVE MIXING

Adapter for use in a planetary mixer

ADAPTER FOR USE IN A PLANETARY MIXER

ORAL LIQUID FORMULATIONS OF LIPID-LOWERING AND BLOOD PRESSURE-LOWERING DRUGS

LIQUID NIMODIPINE COMPOSITIONS

DRUG COCKTAIL FOR TREATMENT OF PARKINSON'S DISEASE, LEWY BODY DISEASE AND MULTIPLE SYSTEM ATROPHY

Topical therapeutic formulations

USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES

METHODS FOR LOWERING BLOOD PRESSURE WITH A DIHYDROPYRIDINE-TYPE CALCIUM CHANNEL BLOCKER PHARMACEUTICAL COMPOSITION

METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES

INHIBITION OF THE HIV-1 REPLICATION BY COMPOUNDS DIRECTED AGAINST A NEW TARGET OF THE VIRAL CYCLE

METHODS FOR TREATING DISEASES MEDIATED BY GLUTATHIONE PEROXIDASE 4

Non-aqueous liquid nimodipine compositions

TOPICAL AMLODIPINE SALTS FOR THE TREATMENT OF ANORECTAL DISEASES

Compositions for the treatment of hypertension

PROPHYLATIC USE OF CALCIUM CHANNEL BLOCKERS IN TUBERCULOSIS

COMPOSITIONS AND METHODS FOR DELAYING THE INCIDENCE OF LABOR

Nimodipine Parenteral Administration

NOVEL THERAPEUTIC USES OF COMPOUNDS FOR ENHANCING MITOCHONDRIAL FUNCTION AND TREATING MITOCHONDRIAL DISEASES

PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT AND/OR PREVENTION OF DIABETES

COLCHICINE DRUG-TO-DRUG INTERACTIONS

ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF

PHARMACEUTICAL COMPOSITION OF SINGLE DOSAGE FORM FOR TREATING OR PREVENTING HYPERTENSION AND HYPERLIPIDEMIA

THERAPEUTIC AGENT NANOPARTICLES AND METHODS OF PREPARATION

Systems, Devices, and Methods for Blood Pressure Control

EFFECTIVE TREATMENTS FOR VASCULAR ASSOCIATED MACULOPATHY, SEVERE MACULOPATHY, LATE-STAGE MACULOPATHY, AND ABERRANT CHORIOCAPILLARIS

METHOD AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF BROAD SPECTRUM VIRUS AILMENTS COMPRISING A CALCIUM CHANNEL BLOCKER OR A CALMODULIN BLOCKER

USE OF HEAT SHOCK PROTEIN INHIBITORS FOR THE TREATMENT OF NEURODEVELOPMENTAL DISORDERS

3D LASER SINTERING PROCESSES FOR IMPROVED DRUG DELIVERY

STABLE PHARMACEUTICAL COMPOSITION OF NIMODIPINE

FORMULATIONS AND METHODS OF TREATING COVID-19 AND PREVENTING INFECTION WITH SARS-CoV-2

DOSAGE REGIMEN OF AMLODIPINE

Pre-Mixed, Ready-To-Use Pharmaceutical Compositions

LIQUISOLID PHARMACEUTICAL FORMULATION AND PROCESS FOR MANUFACTURING

PHARMACEUTICAL COMPOSITION FOR OTIC ADMINISTRATION

CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF

TREATMENT OF PAIN AND VASOCONSTRICTION

Deuterated pharmaceutical compositions and methods of treating cardiovascular diseases

Coated API Particles

Compositions for the treatment of hypertension

Formulations, methods, and systems for treating genitourinary conditions

Topical therapeutic formulations

Pharmaceutical compositions and methods of treating cardiovascular diseases

METHOD TO PREVENT AND TREAT MACULAR DEGENERATION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

Liquid nimodipine compositions

NON-AQUEOUS SUSTAINED RELEASE DRUG DELIVERY SYSTEM

Liquid nimodipine compositions

Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition

DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND ACYLSULFONAMIDES

COMPOSITION CONTAINING LEGOAMODIPINE BESYLATE HYDRATE AND PREPARATION METHOD THEREFOR

USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION

PHARMACOLOGICAL COMPOSITION FOR TREATING PROCTOLOGICAL DISEASES (VARIANTS)

MESOPOROUS POLYMERIC PARTICULATE MATERIAL

Method of increasing platelet counts of a subject

Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations

COMPOSITIONS CONTAINING ANDROGEN RECEPTOR ANTAGONISTS

Short-Acting Dihydropyridines (Clevidipine) For Use in Reducing Stroke Damage

Amlodipine formulations

SS-31 FOR THE PREVENTION AND/OR TREATMENT OF ANEURYSM

MEK INHIBITOR FOR TREATMENT OF STROKE

PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS

Delayed release deferiprone tablets and methods of using the same

AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND SODIUM CATIONS

MICRONEEDLES, AND METHODS FOR THE MANUFACTURE THEREOF

METHODS FOR PREVENTION AND TREATMENT OF FIBROMYALGIA BY CONTACT VASODILATORS

Method of treating focal segmental glomerulosclerosis

Liquid nimodipine compositions

Pharmaceutical compositions and methods of treating cardiovascular diseases

COMPOSITIONS AND METHODS FOR RADIOTHERAPY USING CHELATED RADIOTHERAPEUTIC AGENTS AND NON-TARGET TISSUE BLOCKADE

Pharmaceutical composition of single dosage form for treating or preventing hypertension and hyperlipidemia

ANTI-FIBROTIC NEU3 INHIBITOR COMPOUNDS AND METHODS OF USE

Adhesive patch

TREATING THE CAUSATIVE AGENT IN ADHESIOGENESIS

Non-aqueous liquid nimodipine compositions

Non-Aqueous Liquid Nimodipine Compositions

Clinical assessment of cerebral vasospasm risk following aneurysmal subarachnoid hemorrhage

PROTEIN BASED EXCIPIENT FOR ACTIVE PHARMACEUTICAL INGREDIENTS

Non-aqueous liquid nimodipine compositions

CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES

TOPICAL FORMULATION AND METHODS FOR NEUROPATHY RELIEF

Method of Treatment and Pharmaceutical Composition for Morning Hypertension

TETRAHEDRAL ANTIBODIES

1,4-DIHYDROPYRIDINE COMPOSITIONS, METHODS OF MAKING AND USE

Topical amlodipine salts for the treatment of anorectal diseases

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING LOW IMPURITY CONCENTRATIONS OF THE SAME

Medicaments containing riboflavin exhibiting improved flowability

Delayed release deferiprone tablets and methods of using the same

PHARMACEUTICAL COMPOSITIONS FOR INTRAVENOUS INFUSION IN PLASTIC BAGS WITH REDUCED ADSORPTION ON BAG MEMBRANE

Coated drug compositions and methods of preparing the same

CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS

Methods for treating muscular dystrophies

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

NIMODIPINE INJECTION COMPOSITION AND PREPARATION METHOD THEREFOR

METHODS FOR TREATING GAUCHER DISEASE

METHOD TO PREVENT AND TREAT GINGIVAL RECESSION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

Preeclampsia biomarkers and related systems and methods

Method to prevent and treat macular degeneration by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers

METHOD TO PREVENT AND TREAT OSTEOARTHRITIS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES

THERAPEUTIC AGENT NANOPARTICLES AND METHODS OF PREPARATION

17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure

Compositions containing exosome carrying NF-κB inhibitors and methods of using thereof

Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines

Targeting the renin-angiotensin system for treatment of environment-and pathogen-induced lung injury

ADAPTER FOR USE IN A PLANETARY MIXER

Amlodipine formulations

Adapter for use in a planetary mixer

TREATING DISEASES VIA TARGETED MODULATION OF GENE SIGNALING NETWORKS

Compositions and Methods for Modulating Liver Endothelial Cell Fenestrations

Self-emulsifiable composition, production method therefor, nanoemulsion, and production method therefor

Ferroportin inhibitors

Methods and compositions for the treatment of tuberculosis

METHOD FOR TREATING CARDIOPULMONARY DISORDER

METHOD AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF BROAD SPECTRUM VIRUS AILMENTS COMPRISING A CALCIUM CHANNEL BLOCKER OR A CALMODULIN BLOCKER

1,4-dihydropyridine compositions, methods of making and use

Drug delivery systems comprising solid solutions of weakly basic drugs

Pre-mixed, ready-to-use pharmaceutical compositions

Formulations, methods, and systems for treating genitourinary conditions

Pharmaceutical compositions and methods of treating cardiovascular diseases

Stable nimodipine parenteral formulation

Compositions for the treatment of hypertension

STABLE NIMODIPINE PARENTERAL FORMULATION

Celecoxib and amlodipine formulation and method of making the same

MITOCHONDRIA TARGETING, MPTP REGULATION, AND THE REDUCTION OF MITOCHONDRIAL REACTIVE SPECIES

POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING

Repurposing compounds for the treatment of infections and for modulating the composition of the gut microbiome

Batch-wise melt extrusion process and device for preparing a solid dispersion

Adapter for a dispensing container in a planetary mixer

Adaptor for a dispensing container in a planetary mixer

Methods for Treating Neutrophilic Dermatoses with SYK Inhibitors

Amlodipine formulations

Amlodipine formulations

Method of Treating Focal Segmental Glomerulosclerosis

PHARMACEUTICAL COMPOSITION COMPRISING CLEVIDIPINE AND PROCESS FOR PREPARATION THEREOF

Methods for treating breast cancer using INOS-inhibitory compositions

OSMOTIC PUMP CONTROLLED RELEASE FORMULATIONS

FIXED DOSED PHARMACEUTICAL COMPOSITION COMPRISING AMIODIPINE, CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE FOR THE TREATMENT OF HYPERTENSION

Delayed release deferiprone tablets and methods of using the same

PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS

DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME

Amlodipine formulations

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

Delayed release deferiprone tablets and methods of using the same

ABUSE-PROOFED DOSAGE FORM

Delayed release deferiprone tablets and methods of using the same

TRIMEGESTONE (TMG) FOR TREATMENT OF PRETERM BIRTH

METHODS OF TREATMENT USING NIMODIPINE PARENTERAL FORMULATIONS

METHODS FOR TREATING CARPAL TUNNEL PAIN

Short-Acting Dihydropyridines (Clevidipine) For Use in Reducing Stroke Damage

Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof

Pharmaceutical composition

TREATMENT OF CANCER WITH DIHYDROPYRIDINES

Topical therapeutic formulations

Non-aqueous liquid nimodipine compositions

AQUEOUS DRUG DELIVERY SYSTEM

Methods and compositions for treating ulcers

DRUG DELIVERY SYSTEMS AND METHODS FOR PREPARATION THEREOF

Adapter for use in a planetary mixer

Colchicine drug-to-drug interactions

iNOS-INHIBITORY COMPOSITIONS FOR TREATING CANCER

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations

MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS

Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition

UNIFORM FILMS FOR RAPID DISSOLVE DOSAGE FORM INCORPORATING TASTE-MASKING COMPOSITIONS

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

Topical amlodipine salts for the treatment of anorectal diseases

Ferroportin inhibitors

Compositions for the treatment of hypertension

Pharmaceutical compositions and methods for potentiating gene silencing

ABUSE-PROOFED DOSAGE FORM

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION

MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS

Targeted delivery of drugs to the myometrium via polypeptides that bind to the oxytocin receptor

EX VIVO METHODS FOR PREDICTING AND CONFIRMING IN VIVO METABOLISM OF PHARMACEUTICALLY ACTIVE COMPOUNDS

Celecoxib and amlodipine formulation and method of making the same

Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker

Non-aqueous liquid nimodipine compositions

SMALL MOLECULE THERAPEUTIC COMPOUNDS THAT REDUCE THE INCIDENCE OF INTRACEREBRAL HEMORRHAGE AND BRAIN MICROHEMMORHAGES

Drug target for preventing pathologic calcium overload in cardiomyocytes and methods of screening for same

Hydrogel polymeric compositions and methods

Method for treating cancer with dihydropyridine calcium antagonist

Thiazole inner salt compounds, and preparation methods and uses thereof

Pharmaceutical compositions and methods of treating cardiovascular diseases

Non-aqueous liquid nimodipine compositions

Pharmaceutical compounding methods and systems

Systems and methods for cardiac plexus neuromodulation

Treatment of disorders of sexual arousal with local application of agents that increase membrane excitability

1,4-dihydropyridine derivatives with HSP modulating activity

Methods for treating Gaucher disease

Colchicine drug-to-drug interactions

Colchicine drug-to-drug interactions

Mast cell stabilizers treatment for systemic disorders

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

Delayed release deferiprone tablets and methods of using the same

Pharmaceutical compositions and methods for producing low impurity concentrations of the same

Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures

Deuterated pharmaceutical compositions and methods of treating cardiovascular diseases

FORMULATIONS OF SITE-SPECIFIC, MICROPARTICULATE COMPOSITIONS AND THEIR USE TO IMPROVE OUTCOME AFTER ANEURSYMAL SUBARACHNOID HEMORRHAGE

Pre-mixed, ready-to-use pharmaceutical compositions

ABUSE-PROOFED DOSAGE FORM

Celecoxib and amlodipine formulation and method of making the same

Container assembly

CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS

USE OF sGC STIMULATORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DYSFUNCTION

Topical nifedipine formulations and uses thereof

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

AMORPHOUS DISPERSION GRANULES AND ORAL DOSAGE FORMS

Methods and products for preventing and/or treating microorganism infections comprising iron chelators and non-iron porphyrins

Cooperative Medication Combination Systems

Pharmaceutical compositions and methods of treating cardiovascular diseases

Stable nimodipine parenteral formulation

Stable nimodipine parenteral formulation

Ferroportin inhibitors

Immunoresponsive methods of treating tumors

ORAL SOLUTION OF DIHYDROPYRIDINE DERIVATIVES

Nimodipine Water-Soluble Derivative, And Preparation Method And Use Thereof

Ferroportin inhibitors

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

Anti-hepatitis B virus agent

SOLID DISPERSIONS OF COMPOUNDS USING POLYVINYL ALCOHOL AS A CARRIER POLYMER

Mast cell stabilizers treatment for systemic disorders

METHODS FOR QUANTIFYING PANCREATIC BETA CELL FUNCTION AND MASS PROPERTIES WITH RADIOMANGANESE POSITRON EMISSION TOMOGRAPHY

THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE

AQUEOUS DRUG DELIVERY SYSTEM

Compositions for the treatment of hypertension

DRUG COMBINATIONS FOR CEREBROVASCULAR DISEASE

Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis

Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB polypeptide

Treatment for myopathy

Applications for nicardipine in preparing anti-lung cancer products

SYSTEMS AND METHODS FOR SYMPATHETIC CARDIOPULMONARY NEUROMODULATION

Method of treating focal segmental glomerulosclerosis

Compositions for the treatment of hypertension

Method for preventing lung diseases in smokers and non-smokers using antihypertensive drug

Delayed release pharmaceutical formulation and methods of making and using same

Pharmaceutical compounding methods and systems

Compounds and methods for the treatment of neurodegenerative diseases

Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening

Oral solid dosage form of amlodipine and veterinary uses thereof

Amlodipine formulations

SCALABLE MICROPARTICULATE FORMULATIONS CONTAINING POLYMORPHIC NIMODIPINE FORM 2 PREPARED BY A SOLVENT EVAPORATION PROCESS